Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wagenaar

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Oncologica|May 1, 1997
[What do you mean no anamnestic interview in the cytostatics outpatient clinic?]M Wagenaar
Oncologica|February 21, 1998
[Nursing transfer in chemotherapy]M Wagenaar
Molecules (Basel, Switzerland)|July 4, 2008
Pre-fractionated microbial samples--the second generation natural products library at WyethMelissa M Wagenaar
Journal of Natural Products|August 25, 2001
Dicerandrols, new antibiotic and cytotoxic dimers produced by the fungus Phomopsis longicolla isolated from an endangered mintM M Wagenaar, J Clardy
The Journal of Antibiotics|August 22, 2001
Two new roridins isolated from Myrothecium spM M Wagenaar, J Clardy
Thorax|March 4, 2003
Chronic respiratory failureG P Bootsma, Y Heijdra, M Wagenaar
European Journal of Pharmacology|November 11, 2023
Evolving views on the first two ligands of the angiotensin II type 2 receptor. From putative antagonists to potential agonists?Gerry T M Wagenaar, Gert N Moll
European Journal of Pharmacology|June 23, 2025
Clinical significance of intervention in the renin-angiotensin-aldosterone-apelinergic systemGerry T M Wagenaar, Gert N Moll
Chemosphere|May 13, 2021
Histopathological changes in Oreochromis mossambicus (Peters, 1852) ovaries after a chronic exposure to a mixture of the HIV drug nevirapine and the antibiotics sulfamethoxazole and trimethoprimU M C Nibamureke, G M Wagenaar
European Journal of Pharmacology|January 27, 2025
Advances in the therapeutic potentials of ligands of the apelin receptor APJGerry T M Wagenaar, Gert N Moll
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Oncologica|May 1, 1997
[What do you mean no anamnestic interview in the cytostatics outpatient clinic?]M Wagenaar
Oncologica|February 21, 1998
[Nursing transfer in chemotherapy]M Wagenaar
Molecules (Basel, Switzerland)|July 4, 2008
Pre-fractionated microbial samples--the second generation natural products library at WyethMelissa M Wagenaar
Journal of Natural Products|August 25, 2001
Dicerandrols, new antibiotic and cytotoxic dimers produced by the fungus Phomopsis longicolla isolated from an endangered mintM M Wagenaar, J Clardy
The Journal of Antibiotics|August 22, 2001
Two new roridins isolated from Myrothecium spM M Wagenaar, J Clardy
Thorax|March 4, 2003
Chronic respiratory failureG P Bootsma, Y Heijdra, M Wagenaar
European Journal of Pharmacology|November 11, 2023
Evolving views on the first two ligands of the angiotensin II type 2 receptor. From putative antagonists to potential agonists?Gerry T M Wagenaar, Gert N Moll
European Journal of Pharmacology|June 23, 2025
Clinical significance of intervention in the renin-angiotensin-aldosterone-apelinergic systemGerry T M Wagenaar, Gert N Moll
Chemosphere|May 13, 2021
Histopathological changes in Oreochromis mossambicus (Peters, 1852) ovaries after a chronic exposure to a mixture of the HIV drug nevirapine and the antibiotics sulfamethoxazole and trimethoprimU M C Nibamureke, G M Wagenaar
European Journal of Pharmacology|January 27, 2025
Advances in the therapeutic potentials of ligands of the apelin receptor APJGerry T M Wagenaar, Gert N Moll
Pageof 12